生物
P110α
癌症研究
激酶
遗传学
突变
PI3K/AKT/mTOR通路
信号转导
蛋白质亚单位
基因
作者
Yardena Samuels,Victor E. Velculescu
出处
期刊:Cell Cycle
[Taylor & Francis]
日期:2004-10-12
卷期号:3 (10): 1221-1224
被引量:511
摘要
Phosphatidylinositol 3-kinases (PI3Ks) are important regulators of signaling pathways. To determine whether PI3Ks are genetically altered in human cancers, we recently analyzed the sequences of the PI3K gene family and discovered that one member, the PIK3CA gene encoding the p110alpha catalytic subunit, was frequently mutated in cancers of the colon, breast, brain and lung. The majority of mutations clustered near two positions within the PI3K helical or catalytic domains and at least one hotspot mutation appeared to increase kinase activity. PIK3CA represents one of the most highly mutated oncogenes identified in human cancers and may be a useful diagnostic and therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI